摘要
中国是全球食管癌发病率及死亡率最高的国家。近些年,免疫治疗、靶向治疗等对食管癌治疗策略的制定,产生了深远的影响,但常规治疗方式,如手术、放化疗等,依然不可替代。然而并发症的出现,极大地影响了手术及放化疗的疗效,在一定程度上也影响患者的生存期及生活质量。研究表明,中医药在该领域发挥出了独特优势,为临床提供了有效治疗手段。
China still has the highest incidence and mortality of oesophageal cancer in the world.In recent years,immunotherapy and targeted therapy had a profound impact on the formulation of treatment strategies for esophageal cancer,but conventional treatments such as surgery,radiotherapy and chemotherapy are still irreplaceable.However,the occurrence of complications greatly affects the curative effect of surgery,radiotherapy and chemotherapy,further influence the survival period and life quality of patients to a certain extent.The research show that Chinese medicine has played a unique role in this field,providing effective treatment for the clinic.
作者
盛漫曦
贾瑞诺
张军千
马纯政
郭军辉
陈玉龙
李寒冰
郭志忠
周世繁
张娟
高社干
郑玉玲
张广平
SHENG Man-xi;JIA Rui-nuo;ZHANG Jun-qian;MA Chun-zheng;GUO Jun-hui;CHEN Yu-long;LI Han-bing;GUO Zhi-zhong;ZHOU Shi-fan;ZHANG Juan;GAO She-gan;ZHENG Yu-ling(The First Affiliated Hospital,College of Clinical Medicine of Henan University of Science and Technology,Luoyang,China,471003;The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou,China,450002;The Third Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou,China,450003;School of Medicine,Henan University of Traditional Chinese Medicine,Zhengzhou,China,450046;The First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou,China,450099)
出处
《食管疾病》
2022年第4期286-290,共5页
Journal of Esophageal Diseases
关键词
食管癌
并发症
中医药
esophageal cancer
complications
traditional Chinese Medicine
